Equine Compounding Pharmacies: What Veterinarians Need to Know
Compounding pharmacies serve a critical role in equine medicine. Horses present unique pharmacological challenges — weight-based dosing that far exceeds small-animal ranges, species-specific drug metabolism, and a frequent need for discontinued or commercially unavailable formulations. Compounding fills these gaps.
Why Equine Practitioners Rely on Compounders
Unlike small-animal practice, equine medicine frequently requires medications that simply do not exist in FDA-approved commercial form. Common scenarios include:
- Discontinued drugs — active ingredients pulled from market but still clinically essential
- Dosage form conversion — converting tablets into oral pastes or transdermal gels for horses that resist oral administration
- Strength adjustments — scaling doses for 500–1,200 lb animals when only small-animal concentrations are commercially available
- Combination products — multi-drug formulations to reduce the number of administrations for fractious horses
503A vs. 503B: A Critical Distinction
Under the Drug Quality and Security Act (DQSA), compounding pharmacies operate under two regulatory frameworks:
- 503A Pharmacies
- Traditional compounders that fill individual prescriptions from a licensed veterinarian. Subject to state Board of Pharmacy oversight. Cannot distribute without a patient-specific prescription.
- 503B Outsourcing Facilities
- FDA-registered facilities that can produce compounded drugs in larger quantities without patient-specific prescriptions. Subject to FDA cGMP inspections. Companies like Epicur Pharma operate under this model, supplying veterinary hospitals directly.
Key Accreditations to Evaluate
When selecting a compounding pharmacy for equine patients, practitioners should verify:
- PCAB Accreditation — The Pharmacy Compounding Accreditation Board sets standards beyond state minimums. Hagyard Pharmacy is among the few veterinary pharmacies holding this seal.
- State licensing scope — Pharmacies like Hagyard are licensed in 40+ states; others may be limited to regional service.
- USP 797/800 compliance — Essential for sterile compounding (injectables, ophthalmics). Ensures cleanroom standards and beyond-use dating accuracy.
Common Equine Compounded Medications
| Medication | Common Use | Typical Form |
|---|---|---|
| Omeprazole | Equine gastric ulcer syndrome (EGUS) | Oral paste, injectable |
| Pergolide | Pituitary pars intermedia dysfunction (PPID) | Oral suspension, tablets |
| Methocarbamol | Muscle relaxation, tying-up episodes | Injectable, oral |
| Cisapride | GI motility disorders | Oral suspension |
| Trichlormethiazide + Dexamethasone | Edema, inflammation | Oral powder |
Racing and Competition Compliance
For equine practitioners serving racehorses and competition horses, compounding pharmacy selection has regulatory implications beyond drug quality. The Association of Racing Commissioners International (ARCI) and FEI maintain controlled substance and withdrawal time guidelines. Pharmacies experienced in the racing industry — particularly those in Kentucky’s Thoroughbred corridor like Hagyard and Rood & Riddle — understand these requirements and can advise on withdrawal periods and detection thresholds for compounded formulations.